Toward Global Identification Of Medicinal Products Implementation: A Focus On Biologics

Toward Global Identification of Medicinal Products (IDMP) Implementation: A Focus on Biologics

U.S. Food and Drug Administration

Identification of Medicinal Products: Path to Global Implementation

U.S. Food and Drug Administration

Toward Global IDMP Implementation: A Focus on Global Use Cases

U.S. Food and Drug Administration

IDMP in a capsule Tutorial

Identification of Medicinal Products (IDMP): What is IDMP and Why Should I Care? – June 13, 2019

U.S. Food and Drug Administration

UNICOM - Clinical applications for IDMP

Public Meeting: Patient-Focused Drug Development for Vitiligo

U.S. Food and Drug Administration

Unique Device Identification Webinar #7 - Global manufacturer UDI learnings, 22 March 2022

Master Revised Schedule M – New Critical Requirements for Manufacture of Oral Solid Dosage Forms

Pharma Best Practices Webinars

Technical workshop on real world metadata for regulatory purposes

European Medicines Agency

2021 CLSI Future Focus Forum

Clinical and Laboratory Standards Institute

Biosimilars: Patient and Physician Perspectives

Webinar: “Towards a Smooth Transition to ISO IDMP”

Characterizing FDA’s Approach to Benefit-Risk Assessment throughout the Medical Product Life Cycle

Increasing the Efficiency of Biosimilar Development Programs (Day 1)

U.S. Food and Drug Administration

Regulatory Education for Industry (REdI) Annual Conference 2022 - Day 3

U.S. Food and Drug Administration

FDA's Sentinel Initiative - Pharmacovigilance 2020

U.S. Food and Drug Administration

How Big Pharma is Extending the Pandemic

Vaccines and Related Biological Products Advisory Committee – 6/10/2021

U.S. Food and Drug Administration